IGF-1 Genome-Edited Human MSCs Exhibit Robust Anti-Arthritogenicity in Collagen-Induced Arthritis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25084442 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Dong-Sik Chae und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Catholic Kwandong University College of Medicine, International St. Mary's Hospital, Incheon 22711, Republic of Kor…. Hauptthemen laut MEDLINE: Arthritis, Experimental, Mesenchymal Stem Cells, Insulin-Like Growth Factor I, Gene Editing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, National Research Foundation (NRF) of Korea grants funded by the Korean Government, Ministry of Health & Welfare, Republic of Korea.
Abstract (Originalsprache)
Stem cell therapy stands out as a promising avenue for addressing arthritis treatment. However, its therapeutic efficacy requires further enhancement. In this study, we investigated the anti-arthritogenic potential of human amniotic mesenchymal stem cells (AMM) overexpressing insulin-like growth factor 1 (IGF-1) in a collagen-induced mouse model. The IGF-1 gene was introduced into the genome of AMM through transcription activator-like effector nucleases (TALENs). We assessed the in vitro immunomodulatory properties and in vivo anti-arthritogenic effects of IGF-1-overexpressing AMM (AMM/I). Co-culture of AMM/I with interleukin (IL)-1β-treated synovial fibroblasts significantly suppressed NF-kB levels. Transplantation of AMM/I into mice with collagen-induced arthritis (CIA) led to significant attenuation of CIA progression. Furthermore, AMM/I administration resulted in the expansion of regulatory T-cell populations and suppression of T-helper-17 cell activation in CIA mice. In addition, AMM/I transplantation led to an increase in proteoglycan expression within cartilage and reduced infiltration by inflammatory cells and also levels of pro-inflammatory factors including cyclooxygenase-2 (COX-2), IL-1β, NF-kB, and tumor necrosis factor (TNF)-α. In conclusion, our findings suggest that IGF-1 gene-edited human AMM represent a novel alternative therapeutic strategy for the treatment of arthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Catholic Kwandong University College of Medicine, International St. Mary's Hospital, Incheon 22711, Republic of Korea.
- Department of Family Medicine, Dong-A University College of Medicine, Dong-A University Medical Center, Busan 49236, Republic of Korea.
- Department Medicine, Catholic Kwandong University College of Medicine, Gangneung 25601, Republic of Korea.
Förderung
- National Research Foundation of Korea
- National Research Foundation (NRF) of Korea grants funded by the Korean Government
- Ministry of Health & Welfare, Republic of Korea
Zitieren
APA
Chae, D. S., Han, S., & Kim, S. W. (2024). IGF-1 Genome-Edited Human MSCs Exhibit Robust Anti-Arthritogenicity in Collagen-Induced Arthritis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084442
Vancouver
Chae DS, Han S, Kim SW. IGF-1 Genome-Edited Human MSCs Exhibit Robust Anti-Arthritogenicity in Collagen-Induced Arthritis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084442
BibTeX
@article{Chae2024,
author = {Chae, Dong-Sik and Han, Seongho and Kim, Sung-Whan},
title = {IGF-1 Genome-Edited Human MSCs Exhibit Robust Anti-Arthritogenicity in Collagen-Induced Arthritis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25084442}
}
EUVIMED